CN105377259A - 提高药物和膳食补充剂的细胞吸收的方法和产品 - Google Patents
提高药物和膳食补充剂的细胞吸收的方法和产品 Download PDFInfo
- Publication number
- CN105377259A CN105377259A CN201480028295.1A CN201480028295A CN105377259A CN 105377259 A CN105377259 A CN 105377259A CN 201480028295 A CN201480028295 A CN 201480028295A CN 105377259 A CN105377259 A CN 105377259A
- Authority
- CN
- China
- Prior art keywords
- dietary supplement
- family member
- tetrandrine
- tetrandrine family
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361793028P | 2013-03-15 | 2013-03-15 | |
| US61/793,028 | 2013-03-15 | ||
| PCT/US2014/024649 WO2014150959A2 (en) | 2013-03-15 | 2014-03-12 | Method and products for enhancing cellular uptake of drug and dietary supplements |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105377259A true CN105377259A (zh) | 2016-03-02 |
Family
ID=51529978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480028295.1A Pending CN105377259A (zh) | 2013-03-15 | 2014-03-12 | 提高药物和膳食补充剂的细胞吸收的方法和产品 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9254323B2 (https=) |
| EP (1) | EP3038655A4 (https=) |
| JP (1) | JP2016514143A (https=) |
| KR (1) | KR20150141970A (https=) |
| CN (1) | CN105377259A (https=) |
| MX (1) | MX2015013160A (https=) |
| WO (1) | WO2014150959A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105357966A (zh) * | 2013-03-15 | 2016-02-24 | Cba制药公司 | 提高药物和膳食补充剂的生物利用度的方法和产品 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124315A (en) * | 1989-09-28 | 2000-09-26 | Cancer Biologics Of America, Inc. | Method for potentiating primary drugs in treating multidrug resistant disease |
| CN102600159A (zh) * | 2012-03-09 | 2012-07-25 | 深圳松乐生物科技有限公司 | 含有粉防己碱及粉防己碱类衍生物和氟喹诺酮类药物的组合物及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5332747A (en) | 1989-09-28 | 1994-07-26 | Cancer Biologics Of America, Inc. | Method for potentiating primary drugs in treating multidrug resistant parasitic disease cells |
| AU673142B2 (en) | 1991-04-19 | 1996-10-31 | Cba International, Inc. | Method for potentiating primary drugs in treating multidrug resistant cells |
| US6086915A (en) * | 1998-04-01 | 2000-07-11 | Bioresponse L.L.C. | Compositions and methods of adjusting steroid hormone metabolism through phytochemicals |
| US6350476B1 (en) | 2000-05-22 | 2002-02-26 | Shanxi Zhengzhon Pharmaceutical Co., Ltd. | Herbal chinese joint complex |
| WO2014043347A1 (en) * | 2012-09-13 | 2014-03-20 | Cba Pharma, Inc. | Mdr method and products for treating mrsa |
| CN105357966A (zh) * | 2013-03-15 | 2016-02-24 | Cba制药公司 | 提高药物和膳食补充剂的生物利用度的方法和产品 |
-
2014
- 2014-03-12 MX MX2015013160A patent/MX2015013160A/es unknown
- 2014-03-12 JP JP2016501594A patent/JP2016514143A/ja active Pending
- 2014-03-12 US US14/206,739 patent/US9254323B2/en active Active
- 2014-03-12 EP EP14770474.6A patent/EP3038655A4/en not_active Withdrawn
- 2014-03-12 CN CN201480028295.1A patent/CN105377259A/zh active Pending
- 2014-03-12 KR KR1020157029674A patent/KR20150141970A/ko not_active Ceased
- 2014-03-12 WO PCT/US2014/024649 patent/WO2014150959A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124315A (en) * | 1989-09-28 | 2000-09-26 | Cancer Biologics Of America, Inc. | Method for potentiating primary drugs in treating multidrug resistant disease |
| CN102600159A (zh) * | 2012-03-09 | 2012-07-25 | 深圳松乐生物科技有限公司 | 含有粉防己碱及粉防己碱类衍生物和氟喹诺酮类药物的组合物及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3038655A2 (en) | 2016-07-06 |
| US20140275157A1 (en) | 2014-09-18 |
| WO2014150959A2 (en) | 2014-09-25 |
| KR20150141970A (ko) | 2015-12-21 |
| MX2015013160A (es) | 2016-04-04 |
| WO2014150959A3 (en) | 2015-01-22 |
| US9254323B2 (en) | 2016-02-09 |
| EP3038655A4 (en) | 2017-01-18 |
| JP2016514143A (ja) | 2016-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116785301A (zh) | 含醋酸阿比特龙的药物组合物及其制备方法和应用 | |
| US20140275139A1 (en) | Mdr method and products for treating hiv/aids | |
| WO2024082724A1 (en) | Pim kinase inhibitor in combination with kras inhibitor | |
| CN113082039B (zh) | 一种用于治疗索拉菲尼耐药肿瘤的组合物及其应用 | |
| JP2012505830A5 (https=) | ||
| WO2014043347A1 (en) | Mdr method and products for treating mrsa | |
| CN105377259A (zh) | 提高药物和膳食补充剂的细胞吸收的方法和产品 | |
| US9345257B2 (en) | Method and products for enhancing drug and dietary supplement bioavailability | |
| CN104936585B (zh) | 包括苯肾上腺素和扑热息痛的组合药剂 | |
| KR20180039187A (ko) | 게실증의 치료를 위한 방법 및 조성물 | |
| US20140275138A1 (en) | Method and products for treating diabetes | |
| CN104398517A (zh) | 乙胺嘧啶的新用途及治疗肿瘤的药物组合物 | |
| JP5241127B2 (ja) | 鎮痛用組成物 | |
| CN111558045A (zh) | 一种治疗肺癌的药物组合物 | |
| CN106806382B (zh) | 抗癌组合物 | |
| CN115089576B (zh) | 木犀草素和菊苣酸联合在制备乳腺癌治疗药物中的应用 | |
| JP2014097968A (ja) | 医薬組成物 | |
| CN103263405B (zh) | 用于治疗糖尿病的药物组合物及其应用 | |
| JP2007137896A (ja) | イブプロフェン含有医薬製剤 | |
| Murali | Treatment of Iron Deficiency After Gastric Bypass—Reply | |
| CN117180264A (zh) | 五味子乙素在制备镇痛药物中的应用 | |
| Doshi et al. | Furazolidone (Furazolidine) | |
| CN117752665A (zh) | 熊果酸作为柳氮磺吡啶抗肝癌增敏剂的用途 | |
| CN100406064C (zh) | 用于治疗由幽门螺杆菌感染引起的疾病的制剂 | |
| CN102309492A (zh) | 一种替加氟、吉美斯特和奥替拉西钾复方注射液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160302 |